Supplementary Data from Effects of Siltuximab on the IL-6–Induced Signaling Pathway in Ovarian Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figures S1-S2 and Supplementary Tables S1-S3.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362426653
